Key statistics
On Friday, Prestige Consumer Healthcare Inc (PBV:FRA) closed at 66.00, -3.65% below its 52-week high of 68.50, set on Mar 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 65.50 |
---|---|
High | 66.00 |
Low | 65.50 |
Bid | 65.50 |
Offer | 66.00 |
Previous close | 66.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.56m |
Free float | 48.90m |
P/E (TTM) | 17.87 |
Market cap | 3.62bn USD |
EPS (TTM) | 4.09 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 15:14 BST.
More ▼
Announcements
- Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
- Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
- Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
- Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
- Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
- Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
- Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
More ▼